Tailor-designed deep eutectic liquids as a sustainable extraction media: An alternative to ionic liquids
Publication date: Available online 27 May 2019Source: Journal of Pharmaceutical and Biomedical AnalysisAuthor(s): Selin ŞahinAbstractOne of the main issues of Green Chemistry, encouraging innovative technologies, where incorporates solutions to reduce or eliminate existing pollution problems, is the development of novel green solvents. Therefore, design of environmentally friendly solvents has had a strategic preface in the framework of green technologies recently. When looking at the last 20 years, it is seen that Ionic Liquids (IL) has attracted attention as new generation green design solvents. However, IL has disadvantages such as toxicity, poor biological degradability and high cost, except for the green-labelled properties of solvents (volatile, non-flammable and reusability). Hence, efforts have been made to develop extremely inexpensive solvents at a minimal level of harm to the environment in addition to the present attractive properties of IL. Deep Eutectic Liquid (DEL), which has been lately introduced concept in the literature, is a novel tailor-made solvent. Furthermore, the relevant liquids exhibit physicochemical properties similar to those of conventional ionic liquids, but DELs are much cheaper and environmentally friendly. Due to its advantages, there is a growing interest in many of the research areas such as catalysis, organic synthesis, extraction processes, electrochemistry and material chemistry.Graphical Abstract
Conclusions: Although persons with AD are often collectively considered as expensive patient group, there is large temporal and inter-individual variation in belonging to the highest decile of hospitalization and/or medication costs. It would be important to assess whether hospitalization rate could be decreased by, e.g., comprehensive outpatient care with more efficient management of comorbidities. In addition, other interventions that could decrease hospitalization rate in persons with dementia should be studied further in this context. Key messages Persons with AD had large individual fluctuation in hospital care costs ...
Conclusion and Significance: Understanding the participants' lived experiences raised consciousness of the injustices that exist before and during rehabilitation which uncovered pointers to improve local substance addiction rehabilitation programs: use of occupation-based social participation interventions, limitation of occupational therapy services due to lack of human resources reinforcing interprofessional collaboration, a participatory approach is essential in discussing and addressing injustices, and deliberate use of political activities of daily living. PMID: 31322976 [PubMed - as supplied by publisher]
Publication date: August 2019Source: Neuropsychologia, Volume 131Author(s):
ConclusionDespite the use of AEDs in the majority of patients, only one-third were seizure-free. Other challenges included polypharmacy, the use of valproate in women, and variable adherence. This points to a need for closer follow-up in patients with JME.Graphical abstract
POLLEN COUNT for most parts of the UK have been forecasted by the Met Office. What is the pollen count for today and how can you better manage your symptoms?
A Pennsylvania school district notified parents, whose children had a meal debt of $10 or more, of the potential consequence but officials said the letter was not sanctioned by the superintendent.
This article reviews targeted therapy treatment options for patients with metastatic BC, including strategies for administration, side effects, and nursing considerations. PMID: 31322617 [PubMed - in process]
Chief medical correspondent Dr. Jon LaPook joined "CBS Weekend News" to discuss how to stay ahead of the symptoms that contributed to the deaths of at least six people
Authors: Plagens-Rotman K, Przybylska R, Gerke K, Jaracz K, Serafinowska J, Sadowska-Przytocka A, Adamski Z, Czarnecka-Operacz M PMID: 31320864 [PubMed]
Authors: Kupryś-Lipińska I, Pałczyński C, Molinska J, Kuna P PMID: 31320863 [PubMed]